DIFFERENTIATED THYROID CARCINOMA (DTC) PATIENTS REFFERED FOR RADIOACTIVE IODINE THERAPY AT FIRST PRESENTATION : A 10-YEAR REVIEW

Authors

  • Jiraporn SRIPRAPAPORN Department of Radiology, Faculty of Medicine, Siriraj Hospital
  • Pawana PUSUWAN Department of Radiology, Faculty of Medicine, Siriraj Hospital
  • Sunanta CHIEWVIT Department of Radiology, Faculty of Medicine, Siriraj Hospital
  • Rudee PLEEHACHINDA Department of Radiology, Faculty of Medicine, Siriraj Hospital

Keywords:

thyroid cancer, differentiated thyroid carcinoma, radioactive iodine, iodine-131

Abstract

OBJECTIVE: To evaluate the patient characteristics, histological subtype, presenting symptoms and metastatic evidence in thyroid cancer patients referred for radioactive 1odine (RAT) therapy at first presentation.

METHODS: A retrospective study of patients with differentiated thyroid carcinoma (DTC) registered at Nuclear Medicine Section, Siriraj Hospital during January 1989 to December 1998 was reviewed.

RESULTS: Five hundreds and sixty-six DTC patients, aged 9-96 years (mean=46.8±16.7), including 440 women and 126 men were analyzed. The overall female/male ratio was 3.5:1. According to the histopathology, 370 papillary carcinomas (65.4%), 191 follicular carcinomas (33.7%), 5 Hiirthle cell carcinomas (0.9%) were found. The most common age group was in the range of 31-60 years, accounting for 56% of all patients. There was at least one organ metastasis at first presentation in 235 cases (41.5%). Lymph node is the most often involved organ found in 169 cases (29.9%), followed by lung (52 cases, 9.2%) and bone (49 cases, 8.7%). Ninety-one patients (16.1%) revealed distant metastases at the time of referral. Papillary thyroid carcinomas most commonly metastasize to regional lymph node (39.7%) followed by lung (8.4%), and bone (4.3%), while follicular carcinoma more often metastasize to bone (17.3%) and lung (10.5%).

CONCLUSION: DTC is not uncommon in Thais and affects women rather than men. Papillary carcinoma is the most common histological subtype followed by follicular carcinoma. Since the prevalence of regional node and distant metastases is quite high at presentation, early diagnosis and appropriate treatment are essential for improving the disease outcomes.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Silverberg E, Lubera JA. Cancer statistics 1989, CancerJ Clin. 1989;39:3-20.

Tumor registry, Siriraj Cancer Center, Faculty of Medicine, Siriraj Hospital. Statistical Report 1989-1998.

Harbert JC. Radioiodine therapy of differentiated thyroid carcinoma. In: Harbert JC, Eckelman WC, Neumann RD (eds): Nuclear Medicine Diagnosis and Therapy. Thiem Medical Publisher Co., New York. 1996:975-1019.

Mazzaferri EL, Young RL, Oertel JE, Kemmerer WT, Page CP. Papillary thyroid carcinoma: The impact of therapy in 576 patients. Medicine 1977;56:171-196.

Young RL, Mazzaferri EL, Rahe AJ, Dorfman SG. Pure follicular thyroid carcinoma: impact of therapy in 214 patients. J Nucl Med1980;21:733-737.

Herley JR, Becker DV. The use of radioactive iodine in the management of thyroid cancer. In: Freeman LM, Weissman HS (eds): Nuclear Medicine Annual. Raven Press, New York. 1983:329-384.

Harwood J, Clark OH, Dunphy JE. Significance of lymph node metastasis in differentiated thyroid cancer. Am J Surg 1978;136:107-112.

Hurley JR, Becker DV. Treatment of thyroid cancer with radioiodine (131I) In: Sandler MP, Coleman RE, Wackers FJ TH, Patton JA, Gottschalk A, Hoffer PB, eds. Diagnostic Nuclear Medicine, 3rd edition, Vol 2. Philadelphia, Williams and Wilkins 1996:959-989.

Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med, 1994;97:418-428.

Pomorski L, Cywinski J, Rybinski K. Cancer in hyperthyroidism. Neoplasma 1996;43:217-219.

Zanella E, Rulli F, Muzi M, et al. Prevalence of thyroid cancer in hyperthyroid patients treated by surgery. WorldJ Surg 1998; 22:473-477.

Vaiana R, Cappelli C, Perini P, et al. Hyperthyroidism and concurrent thyroid cancer. Tumori 1999;85:247-252.

Caplan RH, Abellera RM, Kisken WA. Hurthle cell neoplasms of the thyroid gland: reassessment of functional capacity. Thyroid 1994;4:243-248.

Maxon HR III, Smith SD. Radioiodine- 131 in the diagnosis and treatment of metastatic well-differentiated thyroid cancer. Endocrinol Metab Clin North Am 1990;19:685-718.

Downloads

Published

2023-04-13

How to Cite

1.
SRIPRAPAPORN J, PUSUWAN P, CHIEWVIT S, PLEEHACHINDA R. DIFFERENTIATED THYROID CARCINOMA (DTC) PATIENTS REFFERED FOR RADIOACTIVE IODINE THERAPY AT FIRST PRESENTATION : A 10-YEAR REVIEW. ASEAN J Radiol [Internet]. 2023 Apr. 13 [cited 2024 Dec. 9];7(1):55-62. Available from: https://www.asean-journal-radiology.org/index.php/ajr/article/view/554

Issue

Section

Original Article

Most read articles by the same author(s)

Similar Articles

1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.